Although overexpression of wild-type BRAF has been reported to be an underlying mechanism of pathway activation in experimental systems [15], to the best of our knowledge the level of BRAF expression in tumors wild-type for BRAF has not been investigated as a potential predictive and prognostic factor in melanoma patients. Here, BRAF is linked to melanoma.